Accessibility: Skip TopNav
Chi Li
Editas Medicine today announced that it named Chi Li, Ph.D., MBA, RAC, as the Company’s Senior Vice President and Chief Regulatory Officer.
Format
JPEG
Quelle:
Editas Medicine, Inc.
Downloads
Originalgröße
Groß
Mittel
Klein